Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Heterogeneous nuclear ribonucleoprotein A1 pseudogene (ENSG00000228814) is a non-coding genomic locus related to the functional HNRNPA1 gene, which encodes an RNA-binding protein involved in pre-mRNA processing and alternative splicing[3][5]. As a pseudogene, this locus does not produce a functional protein and is not considered a therapeutic target or a component of canonical molecular classifications. Numerous HNRNPA1 pseudogenes exist in the human genome, but none are known to contribute to protein function, disease, or serve as drug targets[3]. Summary of correctness: - This target is not a valid therapeutic target or physiologically relevant molecule; it represents a pseudogene arising from the duplication or retrotransposition of the active HNRNPA1 gene. - It is not a receptor, not a drug target, nor involved in well-defined biological pathways. - Any data on protein functionality, disease relevance, or druggability for HNRNPA1 does not apply to this pseudogene entry. If you need structured information about the functional HNRNPA1 protein instead, that can be provided separately.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene.